In 2020, the DNBSEQ-T7 Gene Sequencer of Wuhan MGI Technology Co., Ltd. (hereinafter referred to as “MGI”) was approved (Registration No.: G.X.Z.Z. 20,203,220,061).

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

据市场研究和咨询公司Coherent Market Insights的最新报告，美国全球聚合酶链式反应市场（PCR）2017年价值37亿美元，预计到2025年，预测期内（2017-2025）的复合年增长率将达8.8％，超过74亿美

Video-assisted lobectomies performed withpowered staplers resulted in nearly half as many patient bleeding complicationsas those conducted with manual staplers, according to a recent study. Patients treated with powered staplers wererelease

CerTest Biotec (Zaragoza, Spain), a biotechnologycompany focused on the development and manufacturing of IVD diagnosticproducts, has opened a new facility in Spain for the research, development andmanufacture of molecular diagnostics produc

RainbowGenomics said recently that it is partnering with Color to provide hereditary cancer and heart health genetic risk assessment testsin Hong Kong. Rainbow, a preferred partner of Color in Hong Kong, willoffer that firms genetic tests f

Grail has raised $300 million in a Series C financing round that wasoversubscribed, according to the firm.Ally Bridge Group led the round alongwith Hillhouse Capital Group and 6 Dimensions Capital. Blue Pool Capital, ChinaMerchant Securitie

Freenome has initiated a clinical study tohelp bring an AI-Genomics blood test for colorectal cancer to the U.S. market. Freenome is looking to build a diagnostictest that can learn from its mistakes. The South San Francisco, CA- basedcompa